Symptoms and General Pathology

All Conditions

Nervous System Diseases

Urinary Tract, Sexual Organs, and Pregnancy Conditions

Wounds and Injuries

Rare Diseases

Death

Cerebral Palsy

Body Weight

Premature Birth

Paralysis

Necrosis

Birth Weight

Brain Injuries

Brain Diseases

Central Nervous System Diseases

Craniocerebral Trauma

Trauma, Nervous System

Brain Damage, Chronic

Chronic Graft Versus Host Disease

Anti-Inflammatory Agents

All Drugs and Chemicals

Antineoplastic Agents

Analgesics

Interleukin-2

William Oh, MD

Michele C. Walsh, MD MS

Ronald N. Goldberg, MD

Barbara J. Stoll, MD

James A. Lemons, MD

Abhik Das, PhD

David K. Stevenson, MD

Waldemar A. Carlo, MD

Neil N. Finer, MD

Edward F. Donovan, MD

Shahnaz Duara, MD

Lu-Ann Papile, MD

Sheldon B. Korones, MD

Jon E. Tyson, MD MPH

Abbot R. Laptook, MD

T. Michael O'Shea, MD MPH

Seetha Shankaran, MD

Richard A. Ehrenkranz, MD

This observational study assessed whether measurements of certain pro-inflammatory and anti-inflammatory cytokines in the blood (either singly or in combination) at birth and/or up to day of life 21 can predict cerebral palsy at 18-22 months corrected age.

Inflammatory cytokines \[interleukin-1 (IL-1β), IL-8, IL-9, tumor necrosis factor-α (TNF-α), and RANTES\] but not anti-inflammatory cytokines released during the perinatal period have been associated with the development of periventricular leukomalacia (PVL) and cerebral palsy (CP) in near term and term infants. However, because blood samples were obtained on any day between day 1 and 18, these data cannot distinguish between prenatal and postnatal effects on neurological outcome. Furthermore, very low birth weight infants who are at the highest risk have not been studies.

The goal of this study was to measure pro-inflammatory and anti-inflammatory cytokine levels at various times in the perinatal period (at birth up to day of life 21), since they may be elevated at different points in the disease process. Blood samples (whole blood spots, dried on filter paper) were obtained on day 1 within 4 hours after birth, and on days 3, 7, 14, and 21. Neurodevelopmental assessments were conducted at 18-22 months corrected age.

Whole blood spots collected on filter paper.

Inflammatory Cytokines Associated With Perinatal Brain Injury

A Study to Determine If Inflammatory Cytokines Are Associated With Perinatal Brain Injury and Long Term Neurodevelopmental Handicap or Death

Centers for Disease Control and Prevention

National Center for Research Resources (NCRR)

NICHD Neonatal Research Network

Waldemar A. Carlo, MD, Lead Principal Investigator

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization	Link
Inflammatory Cytokines Associated With Perinatal Brain Injury	NCT01035697	Infant, Newborn Infant, Low Bir... Infant, Small f... Infant, Prematu... Cerebral Palsy		- 72 Hours	NICHD Neonatal Research Network
Inflammatory Cytokines Associated With Perinatal Brain Injury	NCT01035697	Infant, Newborn Infant, Low Bir... Infant, Small f... Infant, Prematu... Cerebral Palsy		- 72 Hours	NICHD Neonatal Research Network

Spots Global Cancer Trial Database for infant, small for gestational age